Janus Henderson Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.3M Buy
1,401,260
+154,890
+12% +$1.92M 0.01% 593
2025
Q1
$14.3M Buy
+1,246,370
New +$14.3M 0.01% 637